Clinical Trials Logo

Clinical Trial Summary

The dengue, Zika and chikungunya arboviruses represent potentially severe infections to which the New Caledonian population is exposed. In the absence of specific treatment or vaccine, vector control remains the method of choice to limit their spread. However, the traditional methods of prevention and vector control measure today face their limits: mosquito resistance to insecticides, difficulty of access and destruction of breeding areas... The World Mosquito Program Noumea project is based on the artificial colonization of the mosquito vector Aedes aegypti by the endosymbiotic bacteria Wolbachia, which reduces its ability to transmit arboviruses. The breeding of mosquitoes carrying the bacterium Wolbachia in the laboratories of the Institut Pasteur of New Caledonia requires the use of human blood samples for mosquito gorging. The objective of the research is to generate, maintain and amplify Aedes aegypti Caledonian lineages carrying the Wolbachia bacteria for the planned insect release program in Noumea.


Clinical Trial Description

The dengue, Zika and chikungunya arboviruses represent potentially severe infections to which the New Caledonian population is exposed. In the absence of specific treatment or vaccine, disease vector control remains the method of choice to limit their spread. However, the traditional methods of prevention and disease vector control must today face their limits: mosquito resistance to insecticides, difficulty of access and destruction of breeding areas... The World Mosquito Program Noumea project is based on the artificial colonization of the mosquito vector Aedes aegypti by the endosymbiotic bacterium Wolbachia, which reduces its ability to transmit arboviruses. The breeding of mosquitoes carrying the bacterium Wolbachia in the laboratories of the Institut Pasteur of New Caledonia requires the use of human blood samples for mosquito gorging. The objective of the research is to generate, maintain and amplify Aedes aegypti Caledonian lineages carrying the bacterium Wolbachia for the planned insect release program in Noumea. The establishment of Wolbachia in Aedes aegypti populations in Noumea should lead to the reduction of active transmission of dengue, Zika and chikungunya in the municipality. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03552094
Study type Observational
Source Institut Pasteur
Contact Vincent Richard
Phone +687 27.26.66
Email vrichard@pasteur.nc
Status Recruiting
Phase
Start date June 25, 2018
Completion date June 2023

See also
  Status Clinical Trial Phase
Completed NCT01868399 - Pilot Survey of Dengue Fever in Solomon Islands N/A
Recruiting NCT05452447 - Spatial Repellents for Aedes-borne Virus Control in Sri Lanka N/A
Completed NCT03210363 - Sero-epidemiology of Priority Arboviruses in French Guiana N/A
Completed NCT03553277 - Spatial Repellents for Arbovirus Control N/A
Completed NCT00116766 - Field Evaluation of Plant-based Mosquito Control Phase 2
Recruiting NCT04615364 - Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia
Recruiting NCT04954352 - Human Epidemiology of Newly Identified Arboviruses
Completed NCT06268691 - Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating N/A
Recruiting NCT04619823 - Virological and Immunological Determinants of Arbovirus Infection in New Caledonia N/A